论文部分内容阅读
目的:研究脑转移瘤的立体定向放射治疗与临床应用意义。方法:收取我院120例脑转移瘤患者,收取时间在2015年10月20日直至2016年1月27日,并将脑转移瘤患者分为两组,对照组(60例患者实施常规放射治疗),观察组(60例患者实施立体定向放射治疗)。结果:观察组脑转移瘤患者治疗后的中位生存期、1年生存率83.33%、3个月局部控制率86.67%均优于对照组(P<0.05),观察组脑转移瘤患者中,放射性脑水肿患者有1例、食欲不振患者有1例、呕吐患者有1例、并发症发生率5.00%低于对照组患者(P<0.05)。结论:通过对脑转移瘤患者实施立体定向放射治疗,取得较为显著的效果,能降低患者放射性脑水肿、食欲不振、呕吐等并发症,增加中位生存期,提升1年生存率、3个月局部控制率,促进患者康复。
Objective: To study the stereotactic radiation therapy of brain metastases and its clinical significance. Methods: We collected 120 patients with brain metastases in our hospital from October 20, 2015 until January 27, 2016. Patients with brain metastases were divided into two groups. The control group (60 patients underwent routine radiotherapy ), Observation group (60 patients underwent stereotactic radiotherapy). Results: The median survival time of patients with metastatic brain tumor in observation group was 83.33% after 1 year and 86.67% at 3 months (P <0.05). Among the patients with brain metastases, One patient had radioactive cerebral edema, one had loss of appetite, one had vomiting, and the incidence of complications was 5.00% lower than that of the control group (P <0.05). Conclusion: Stereotactic radiotherapy for patients with brain metastases achieved more significant results, which can reduce the complications such as radioactive cerebral edema, loss of appetite and vomiting, increase the median survival time and improve the 1-year survival rate for 3 months Local control rate, promote patient rehabilitation.